Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

TRAMADOL IMPURITY A CRS (20 MG)

TRAMADOL IMPURITY A CRS (20 MG)

NA

DISCOVER
TRAMADOL IMPURITY E CRS (15 MG)

TRAMADOL IMPURITY E CRS (15 MG)

NA

DISCOVER
Xylazine impurity C

Xylazine impurity C

NA

DISCOVER
KETOTIFEN IMPURITY G CRS (0.023 MG)

KETOTIFEN IMPURITY G CRS (0.023 MG)

NA

DISCOVER
COCAINE HYDROCHLORIDE - REFERENCE SPECTRUM (N/A)

COCAINE HYDROCHLORIDE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
Doxylamine hydrogen succinate- reference spectrum

Doxylamine hydrogen succinate- reference spectrum

NA

DISCOVER
TRIBENOSIDE CRS (150 MG)

TRIBENOSIDE CRS (150 MG)

10310-32-4

DISCOVER
TRIBENOSIDE IMPURITY A CRS (70 MG)

TRIBENOSIDE IMPURITY A CRS (70 MG)

53928-30-6

DISCOVER
BENZYL ALCOHOL CRS (70 MG)

BENZYL ALCOHOL CRS (70 MG)

100-51-6

DISCOVER
FLUNITRAZEPAM - REFERENCE SPECTRUM (N/A)

FLUNITRAZEPAM - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
METOPROLOL SUCCINATE - REFERENCE SPECTRUM (N/A)

METOPROLOL SUCCINATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
4-AMINOBENZOIC ACID CRS (60 MG)

4-AMINOBENZOIC ACID CRS (60 MG)

150-13-0

DISCOVER